Loading insider details...
Beta
Latest Form 4 (Oct 5, 2026): Purchase of 228,334 OM shares, $806.0K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 5, 2026 | Outset Medical, Inc. (OM) | Purchase | 228,334 | $806.0K |
| May 18, 2026 | Outset Medical, Inc. (OM) | In-the-Money Exercise | 323,000 | $1.61M |
| May 12, 2026 | Outset Medical, Inc. (OM) | In-the-Money Exercise | 197,600 | $988.0K |
| Apr 27, 2026 | Aclaris Therapeutics, Inc. (ACRS) | Sale | 300,000 | $1.36M |
| Dec 5, 2025 | Adverum Biotechnologies, Inc. (ADVM) | Sale | 524,560 | $2.20M |
| Dec 4, 2025 | Adverum Biotechnologies, Inc. (ADVM) | Sale | 300,000 | $1.26M |
| Oct 8, 2025 | ASTROTECH Corp (ASTC) | Sale | 220,410 | $1.57M |
| Jun 16, 2025 | AN2 Therapeutics, Inc. (ANTX) | Sale | 200,000 | $218.0K |
| May 30, 2025 | AN2 Therapeutics, Inc. (ANTX) | Sale | 2,000,000 | $2.32M |
| Apr 28, 2025 | Adverum Biotechnologies, Inc. (ADVM) | Purchase | 20,407 | $102.8K |